Share your opinion and earn yourself a free Motley Fool premium report!

We are looking for Fools to join a 75 minute online independent market research forum on 15th / 16th December.

To find out more and express your interest please click here

The FTSE 100 has fallen 11% in a week. Here’s my contrarian pick

Here’s a cyclical stock that I believe can hold investors in good stead. 

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

It’s a bad time for stock markets. The coronavirus scare has gripped global markets, leading to a sharp plunge. The FTSE is no exception to this. The FTSE 100 index has fallen by more than 11% in a week, and it might fall even more next week. The unfortunate spread of COVID-19 shows no sign of slowing. It’s easy to think of the worst that can happen at this time, get nervous, and sell off. Or, at the very least, refrain from buying.  

Alternative view 

But consider another perspective. What if the virus were to be contained in the near future? The panicked drop in share prices will look like a time when investments should have been made. Even if markets continue to drop, the fact remains that a number of high-growth and high-dividend stocks are available at huge discounts right now. These stocks have a gravity defying track-record. In other words, there’s limited risk to holding them in our investing portfolio.  

Real estate in focus 

One of these is the FTSE 100 house-builder Persimmon (LSE: PSN), whose share price has fallen by 13.8% since last week. It may sound contrarian to suggest a cyclical stock at a time when economic conditions could take a turn for the worse. But there are three reasons why I still like it.  

One, sure, the stock shows cyclicality in the near term but over the longer term, it’s more likely than not to allow for significant capital gains. Two, it’s one of the only stocks to provide both capital growth and a high passive income. At present, its dividend yield is 8.2%. It also intends to maintain its current level of dividends in the next year at least. With a falling share price, we are essentially looking at potentially even higher yields going forward. Three, UK’s real estate market is picking up, which bodes well for stocks in the sector.  

Not always contrarian 

Outside of real estate, however, I do agree that going contrarian isn’t always the best idea. Last week, I had written about how I’d stay away from financials in the case of a stock market crash. It seemed less likely then, but today I’d start to become more cautious of the sector. 

There are plenty of less contrarian stocks to invest in in any case. Pharmaceuticals and healthcare companies like GlaxoSmithKline and Smith & Nephew are two that I like. Yesterday, I had also written about Diageo, the FTSE 100 alcohol producer, which has been a good investment over the past years. It has warned of the impact on its profits as a result of the virus outbreak, but it’s too soon to say if there will be any longer-term impact on the stock. In this scenario, I’m sticking to Warren Buffett’s advice by getting greedy when others are fearful.       

Manika Premsingh has no position in any of the shares mentioned. The Motley Fool UK owns shares of and has recommended GlaxoSmithKline. The Motley Fool UK has recommended Diageo. Views expressed on the companies mentioned in this article are those of the writer and therefore may differ from the official recommendations we make in our subscription services such as Share Advisor, Hidden Winners and Pro. Here at The Motley Fool we believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

The BP share price could face a brutal reckoning in 2026

Harvey Jones is worried about the outlook for the BP share price, as the global economy struggles and experts warn…

Read more »

Midnight is celebrated along the River Thames in London with a spectacular and colourful firework display.
Investing Articles

How on earth did Lloyds shares explode 75% in 2025?

Harvey Jones has been pleasantly surprised by the blistering performance of Lloyds shares over the last year or two. Will…

Read more »

Group of four young adults toasting with Flying Horse cans in Brazil
Investing Articles

Down 56% with a 4.8% yield and P/E of 13 – are Diageo shares a generational bargain?

When Harvey Jones bought Diageo shares he never dreamed they'd perform this badly. Now he's wondering if they're just too…

Read more »

Number three written on white chat bubble on blue background
Investing Articles

Could these 3 holdings in my Stocks and Shares ISA really increase in value by 25% in 2026?

James Beard’s been looking at the 12-month share price forecasts for some of the positions in his Stocks and Shares…

Read more »

National Grid engineers at a substation
Investing Articles

2 reasons I‘m not touching National Grid shares with a bargepole!

Many private investors like the passive income prospects they see in National Grid shares. So why does our writer not…

Read more »

Number 5 foil balloon and gold confetti on black.
Investing Articles

£10,000 invested in Greggs shares 5 years ago would have generated this much in dividends…

Those who invested in Greggs shares five years ago have seen little share price growth. However, the dividends have been…

Read more »

Rolls-Royce Hydrogen Test Rig at Loughborough University
Growth Shares

Here is the Rolls-Royce share price performance for 2023, 2024, and 2025

Where will the Rolls-Royce share price be at the end of 2026? Looking at previous years might help us find…

Read more »

Investing Articles

This FTSE 250 stock could rocket 49%, say brokers

Ben McPoland takes a closer look at a market-leading FTSE 250 company that generates plenty of cash and has begun…

Read more »